Division of Cardiac Critical Care Medicine, George Washington University, Children's National Medical Center, 111 Michigan Avenue, NW Washington DC, 200010 United States.
Department of Cardiology, Division of Cardiovascular Critical Cares Medicine, Harvard Medical School, Boston Children's Hospital, 300 Longwood Avenue, Boston MA 02115 United States.
Resuscitation. 2019 Sep;142:74-80. doi: 10.1016/j.resuscitation.2019.07.013. Epub 2019 Jul 17.
To evaluate the Inadequate oxygen delivery (IDO) index dose as a predictor of cardiac arrest (CA) in neonates following congenital heart surgery.
Retrospective cohort study in 3 US pediatric cardiac intensive units (1/2011- 8/2016). Calculated IDO index values were blinded to bedside clinicians and generated from data collected up to 30 days postoperatively, or until death or ECMO initiation. Control event data was collected from patients who did not experience CA or require ECMO. IDO dose was computed over a 120-min window up to 30 min prior to the CA and control events. A multivariate logistic regression prediction model including the IDO dose and presence or absence of a single ventricle (SV) was used. Model performance metrics were the odds ratio for each regression coefficient and receiver operating characteristic area under the curve (ROC AUC).
Of 897 patients monitored during the study period, 601 met inclusion criteria: 29 patients had CA (33 events) and 572 patients were used for control events. Seventeen (59%) CA and 125 (26%) control events occurred in SV patients. Median age/weight at surgery and level of monitoring were similar in both groups. Median postoperative event time was 0.73 days [0.05-22.39] in CA patients and 0.82 days [0.08 25.11] in control patients. Odds ratio of the IDO dose coefficient was 1.008 (95% CI: 1.006-1.012, p = 0.0445), and 2.952 (95% CI: 2.952-3.258, p = 0.0079) in SV. The ROC AUC using both coefficients was 0.74 (95% CI: 0.73-0.75). These associations of IDO dose with CA risk remained robust, even when censored periods prior to arrest were 10 and 20 min.
In neonates post-CPB surgery, higher IDO index dose over a 120-min monitoring period is associated with increased risk of cardiac arrest, even when censoring data 10, 20 or 30 min prior to the CA event.
评估供氧不足(IDO)指数剂量作为先天性心脏病手术后新生儿心搏骤停(CA)的预测指标。
这是在美国三个儿科心脏重症监护病房进行的回顾性队列研究(1/2011-8/2016)。计算 IDO 指数值时对床边临床医生进行了盲法处理,并从术后 30 天内或直至死亡或开始 ECMO 时收集的数据中生成。对照事件数据是从未经历 CA 或需要 ECMO 的患者中收集的。IDO 剂量在 CA 和对照事件前 30 分钟至 30 分钟内的 120 分钟窗口内计算。使用包括 IDO 剂量和单心室(SV)存在或不存在的多变量逻辑回归预测模型。模型性能指标为每个回归系数的优势比和接收器操作特征曲线下的面积(ROC AUC)。
在研究期间监测的 897 名患者中,有 601 名符合纳入标准:29 名患者发生 CA(33 例事件),572 名患者用于对照事件。17 例(59%)CA 和 125 例(26%)对照事件发生在 SV 患者中。两组患者的手术年龄/体重中位数和监测水平相似。CA 患者的中位术后事件时间为 0.73 天[0.05-22.39],对照患者为 0.82 天[0.08-25.11]。IDO 剂量系数的优势比为 1.008(95%CI:1.006-1.012,p=0.0445),SV 为 2.952(95%CI:2.952-3.258,p=0.0079)。使用两个系数的 ROC AUC 为 0.74(95%CI:0.73-0.75)。即使在逮捕前的censored 期为 10 分钟和 20 分钟时,IDO 剂量与 CA 风险之间的这种关联仍然很可靠。
在体外循环手术后的新生儿中,120 分钟监测期内较高的 IDO 指数剂量与心搏骤停风险增加相关,即使在 CA 事件前 censored 数据 10、20 或 30 分钟时也是如此。